Santen Pharmaceutical Co (JP:4536) has released an update.
Santen Pharmaceutical Co., Ltd. has completed a share buyback program, repurchasing 3,066,700 common shares for a total of 4.92 billion yen within the period from June 1 to June 30, 2024. This buyback is part of a larger plan, announced by the Board of Directors on May 9, 2024, to buy back up to 21.11 million shares, representing 5.8% of the total shares outstanding, for a maximum total of 38 billion yen by November 6, 2024.
For further insights into JP:4536 stock, check out TipRanks’ Stock Analysis page.
